Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance

American Journal of Hematology

Volumn 54, Issue 3, 1997, Pages 189-195

  Haidar, Mohammad A ^a   El Hajj, Hamid ^a   Bueso Ramos, Carlos E ^a   Manshouri, Taghi ^a   Glassman, Armand ^a   Keating, Michael J ^a   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CLL; MDM 2 oncoprotein; prognosis

Indexed keywords

ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; HUMANS; IMMUNOBLOTTING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR MARKERS, BIOLOGICAL;

EID: 0030992389     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199703)54:3<189::AID-AJH3>3.0.CO;2-S     Document Type: Article

References (25)

1. Holstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991.
2. Mietz JA, Unger T, Huibregtse JM, Howley FM: The transcriptional transactivation function of wild-type p53 Is Inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein, EMBO J 11:5013-5020, 1992.
3. Oliner JD, Kinder KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associa ted protein in human sarcomas. Nature 358:80-83, 1992.
4. Wu X, Bayle JH, Olson D, Levine, AJ: The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126-1132, 1993.
5. Brown DR, Deb S, Munoz RM, Subler MA, Deb SP: The tumor suppressor protein p53 and the oncoprotein Simian Virus 40 T antigen bind to overlapping domains on the MDM2 protein. Mol Cell Blol 13:6849-6857, 1993.
6. Momand J, Zambettl GP, Olson DC, George DL, Levine AJ: The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-medlaled transactivauon. Cell 69:1237-1245, 1992.
7. Ladanyi M, Cha C, Lewis R, J hanwar SC, Huvos AG, Healey JH: MDM2 gene amplification In metastatic osteosarcoma. Cancer Res 53:16-18, 1993.
8. Relfenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP: Amplification and overexpression in the MDM2 gene In a subset of human malignant glioblastomas without p53 mutation. Cancer Res 53:2736-2739, 1993.
9. Olson DC, Marechal V, Momand J, Chen J, Romocki C, Levine AJ: Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes, Oncogene 8:2353-2360, 1993.
10. Landers JE, Haines DS, Strauss III JF, Oeorge L: Enhanced translation: A novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9:2745-2750, 1994.
11. Sheikh MS, Shao Z-M, Hussein A, Fontana JA: The p53-blnding protein MDM-2 gene is differentially expressed in human breast carcinoma. Cancer Res 53:3226-3228, 1993.
12. Gudas JM, Nguyen H, Klein RC, Katayose D, Seth P, Cowan KH: Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin Cancer Res 1:71-80, 1995.
13. Bueso-Ramos CE, Manshourl T, Haidar MA, Yang Y, McCowan P, Ordonez N, Classman A, Snelge N, Albitar M: Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat 37;179-188, 1996.
14. Bueso-Ramos CE, Yang Y, De Leon E, McCown P, Stass SA, Albitar M: The MDM-2 oncogene is overexpressed in leukemias. Blood 82: 2617-2623, 1993.
15. Haines DS, Landers JE, Engle LJ, George DL: Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell Biol 14:1171-1178, 1994.
16. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991.
17. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD: p53: A target for genetic abnormalities in lung cancer. Science 246:491-494, 1989.
18. Imamura J, Miyoshi I, Koeffler HP: p53 in hematological malignancies. Blood 84:2412-2421, 1994.
19. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, Murata T, Saito H: The MDM-2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B cell origin. Blood 84:3158-3165, 1994.
20. Quesnel B, Preudhomme C, Oscier D, Lepelley P, Hooghe MC, Facon T, Zandecki M, Fenaux P: Over-expression of the MDM2 gene is found in some cases of hematological malignancies. Br J Hematol 88:415-418, 1994.
21. Soussi T, Caron de Fromental C, May P: Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952, 1990.
22. Borresen AL, Hovig E, Smith-Sorensen B, Malkin D, Lystad S, Anderson TI, Nesland JM, Isselbacher KJ, Friend S: Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA 88:8405-8409, 1991.
23. Doglioni C, Pelosio P, Mombello A, Scrapa A, Chilosi M: Immunohistochemical evidence of abnormal expression of the anti oncogeneencoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas. Hematol Pathol 5:67-73, 1991.
24. Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P: Detection of p53 mutations in hematological malignancies: Comparison between immunocytochemistry and DNA analysis. Leukemia 8:1342-1349, 1994.
25. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ: Molecular abnormalities of MDM-2 and p53 genes in adult soft tissue sarcomas. Cancer Res 794-799, 1994.